These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 23852693

  • 1. Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma?
    Manetti M, Rosa I, Milia AF, Guiducci S, Carmeliet P, Ibba-Manneschi L, Matucci-Cerinic M.
    Ann Rheum Dis; 2014 Sep; 73(9):1700-9. PubMed ID: 23852693
    [Abstract] [Full Text] [Related]

  • 2. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.
    Manetti M, Romano E, Rosa I, Guiducci S, Bellando-Randone S, De Paulis A, Ibba-Manneschi L, Matucci-Cerinic M.
    Ann Rheum Dis; 2017 May; 76(5):924-934. PubMed ID: 28062404
    [Abstract] [Full Text] [Related]

  • 3. Upregulation of the N-formyl Peptide receptors in scleroderma fibroblasts fosters the switch to myofibroblasts.
    Rossi FW, Napolitano F, Pesapane A, Mascolo M, Staibano S, Matucci-Cerinic M, Guiducci S, Ragno P, di Spigna G, Postiglione L, Marone G, Montuori N, de Paulis A.
    J Immunol; 2015 Jun 01; 194(11):5161-73. PubMed ID: 25917089
    [Abstract] [Full Text] [Related]

  • 4. The absence of uPAR is associated with the progression of dermal fibrosis.
    Kanno Y, Kaneiwa A, Minamida M, Kanno M, Tomogane K, Takeuchi K, Okada K, Ueshima S, Matsuo O, Matsuno H.
    J Invest Dermatol; 2008 Dec 01; 128(12):2792-7. PubMed ID: 18548111
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma.
    Vorstenbosch J, Al-Ajmi H, Winocour S, Trzeciak A, Lessard L, Philip A.
    Arthritis Rheum; 2013 May 01; 65(5):1378-83. PubMed ID: 23436317
    [Abstract] [Full Text] [Related]

  • 8. Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage.
    Manetti M, Guiducci S, Romano E, Bellando-Randone S, Conforti ML, Ibba-Manneschi L, Matucci-Cerinic M.
    Ann Rheum Dis; 2012 Jun 01; 71(6):1064-72. PubMed ID: 22258486
    [Abstract] [Full Text] [Related]

  • 9. Increased plasma soluble urokinase plasminogen activator receptor levels in systemic sclerosis: possible association with microvascular abnormalities and extent of fibrosis.
    Legány N, Toldi G, Distler JH, Beyer C, Szalay B, Kovács L, Vásárhelyi B, Balog A.
    Clin Chem Lab Med; 2015 Oct 01; 53(11):1799-805. PubMed ID: 25894644
    [Abstract] [Full Text] [Related]

  • 10. Recent advances in animal models of systemic sclerosis.
    Asano Y.
    J Dermatol; 2016 Jan 01; 43(1):19-28. PubMed ID: 26782003
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Downregulation of miR-193b in systemic sclerosis regulates the proliferative vasculopathy by urokinase-type plasminogen activator expression.
    Iwamoto N, Vettori S, Maurer B, Brock M, Pachera E, Jüngel A, Calcagni M, Gay RE, Whitfield ML, Distler JH, Gay S, Distler O.
    Ann Rheum Dis; 2016 Jan 01; 75(1):303-10. PubMed ID: 25384965
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis.
    Artlett CM, Sassi-Gaha S, Rieger JL, Boesteanu AC, Feghali-Bostwick CA, Katsikis PD.
    Arthritis Rheum; 2011 Nov 01; 63(11):3563-74. PubMed ID: 21792841
    [Abstract] [Full Text] [Related]

  • 15. Systemic sclerosis fibroblasts inhibit in vitro angiogenesis by MMP-12-dependent cleavage of the endothelial cell urokinase receptor.
    Serratì S, Cinelli M, Margheri F, Guiducci S, Del Rosso A, Pucci M, Fibbi G, Bazzichi L, Bombardieri S, Matucci-Cerinic M, Del Rosso M.
    J Pathol; 2006 Oct 01; 210(2):240-8. PubMed ID: 16917801
    [Abstract] [Full Text] [Related]

  • 16. Myofibroblast induction and microvascular alteration in scleroderma lung fibrosis.
    Beon M, Harley RA, Wessels A, Silver RM, Ludwicka-Bradley A.
    Clin Exp Rheumatol; 2004 Oct 01; 22(6):733-42. PubMed ID: 15638048
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. N-Formyl Peptide Receptors Induce Radical Oxygen Production in Fibroblasts Derived From Systemic Sclerosis by Interacting With a Cleaved Form of Urokinase Receptor.
    Napolitano F, Rossi FW, Pesapane A, Varricchio S, Ilardi G, Mascolo M, Staibano S, Lavecchia A, Ragno P, Selleri C, Marone G, Matucci-Cerinic M, de Paulis A, Montuori N.
    Front Immunol; 2018 Oct 01; 9():574. PubMed ID: 29670612
    [Abstract] [Full Text] [Related]

  • 19. Dipeptidylpeptidase 4 as a Marker of Activated Fibroblasts and a Potential Target for the Treatment of Fibrosis in Systemic Sclerosis.
    Soare A, Györfi HA, Matei AE, Dees C, Rauber S, Wohlfahrt T, Chen CW, Ludolph I, Horch RE, Bäuerle T, von Hörsten S, Mihai C, Distler O, Ramming A, Schett G, Distler JHW.
    Arthritis Rheumatol; 2020 Jan 01; 72(1):137-149. PubMed ID: 31350829
    [Abstract] [Full Text] [Related]

  • 20. A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis.
    Manetti M, Allanore Y, Revillod L, Fatini C, Guiducci S, Cuomo G, Bonino C, Riccieri V, Bazzichi L, Liakouli V, Cipriani P, Giacomelli R, Abbate R, Bombardieri S, Valesini G, Montecucco C, Valentini G, Ibba-Manneschi L, Matucci-Cerinic M.
    Arthritis Rheum; 2011 Jan 01; 63(1):247-56. PubMed ID: 20967855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.